MedTrace Logo

Zinc Oxide VS MEBO

NCT07193849 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2025-09-26

No results posted yet for this study

Summary

randomize control trial to evaluate the efficacy of using zinc oxide versus moist exposed wound ointment in treatment of second stage pressure ulcer.

Conditions

  • Pressure Injury
  • Pressure Injury Stage 2
  • Bedsore
  • Pressure Ulcers Stage II
  • Pressure Ulcer, Buttock

Interventions

DRUG

MEBO Wound Ointment

both are used for second pressure ulcer

DRUG

zinc oxide

both are used to treat second degree pressure ulcer but with no superiority

Sponsors & Collaborators

  • King Abdullah Medical City

    lead OTHER_GOV

Principal Investigators

  • Dr. Ebtisam AbdElatif Ebrahim, Master degree of science in nu · King Abdullah Medical City in Holy Capital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07193849 on ClinicalTrials.gov